Executive Summary
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Chemotherapy Drugs Market. The report analyzes the Chemotherapy Drugs Market, By Type of Drug (Antimetabolites, Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics, Others), By Route of Administration (Oral, Intravenous, Others). The chemotherapy drugs market has been analyzed By Region (North America, Europe, Asia Pacific and Rest of the World) and By Country (U.S, Canada, United Kingdom, Germany, China and India) for the historical period of 2013-2017 and the forecast period of 2018-2023.
According to Azoth Analytics research report "Global Chemotherapy Drugs Market: Analysis By Drug Type (Antimetabolites, Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics), By Administration (Oral, Intravenous), By Region, By Country (2019 Edition): Opportunities and Forecast (2013-2023) - By Region (North America, Europe, Asia Pacific and Rest of the World), By Country (U.S, Canada, United Kingdom, Germany, China and India)", global market is projected to display a robust growth represented by a CAGR of 11.91% during 2018 - 2023.
On the basis of type of chemotherapy drug, plant alkaloids and antitumor antibiotics have been witnessing growth at a noteworthy rate over the past few years backed by effective use of these medications for the treatment of several varieties of cancers such as breast, ovarian, lung, bladder, prostate, melanoma, esophageal, as well as other types of solid tumors, etc. Amongst the regions, North America accounts for the largest regional share in the global chemotherapy drugs market in 2018. However, in the forecast period, the Asia Pacific region is anticipated to advance at the highest pace. Key factors driving the robust growth rate of Asia Pacific region include boosting production of pharmaceuticals, growing incidence of cancer along with government's focus on medical infrastructural developments.
The report titled "Global Chemotherapy Drugs Market: Analysis By Drug Type (Antimetabolites, Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics), By Administration (Oral, Intravenous), By Region, By Country (2019 Edition): Opportunities and Forecast (2013-2023) - By Region (North America, Europe, Asia Pacific and Rest of the World), By Country (U.S, Canada, United Kingdom, Germany, China and India)" has covered and analyzed the potential of global chemotherapy drugs market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global chemotherapy drugs market. Additionally, the report also highlights market entry strategies for various companies across the globe.
Scope of the Report
Global Chemotherapy Drugs Market (Actual Period: 2013-2017, Forecast Period: 2018-2023
• Global Chemotherapy Drugs Market - Size, Growth, Forecast
• By Type of Drug (Antimetabolites, Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics, Others)
• By Route of Administration (Oral, Intravenous, Others)
Regional Markets - North America, Europe, APAC, Rest of the World (Actual Period: 2013-2017, Forecast Period: 2018-2023)
• Regional Chemotherapy Drugs Market - Size, Growth, Forecast
• By Type of Drug (Antimetabolites, Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics, Others)
• By Route of Administration (Oral, Intravenous, Others)
Country Analysis - U.S, Canada, United Kingdom, Germany, China and India (Actual Period: 2013-2017, Forecast Period: 2018-2023)
• Chemotherapy Drugs Market - Size, Growth, Forecast
• By Type of Drug (Antimetabolites, Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics, Others)
• By Route of Administration (Oral, Intravenous, Others)
Other Report Highlights:
• Market Dynamics - Drivers and Restraints
• Market Trends
• SWOT Analysis
• Porter Five Force Analysis
• Policy and Regulatory Landscape
• Company Analysis - Pfizer, Eli Lilly & Company, Celgene Corporation, Bristol-Myers Squibb, Merck & Co., Inc., GlaxoSmithKline plc, Novartis, Sanofi, Teva Pharmaceutical Industries Limited.
Customization of the Report
The report could be customized according to the client's specific research requirements. No additional cost will be required to pay for limited additional research.
Table of Contents
1. Research Methodology
2. Executive Summary
3. Strategic Recommendations
4. Chemotherapy Drugs Market Outlook
5. Global Chemotherapy Drugs Market: Growth and Forecast
5.1 By Value (2013-2017)
5.2 By Value (2018-2023)
6. Global Chemotherapy Drugs Market: Segment Analysis
6.1 Global Antimetabolite Chemotherapy Drugs Market, By Value (2013-2023)
6.2 Global Plant Alkaloid Chemotherapy Drugs Market, By Value (2013-2023)
6.3 Global Antitumor Antibiotic Chemotherapy Drugs Market, By Value (2013-2023)
6.4 Other Chemotherapy Drugs Market, By Value (2013-2023)
6.5 Global Chemotherapy Drugs Market Size, By Route of Administration: Breakdown (%)
6.5.1 Global Chemotherapy Drugs Market Size, By Route of Administration, 2017 (%)
6.5.2 Global Chemotherapy Drugs Market Size, By Route of Administration, 2023 (%)
6.6 Global Intravenous Chemotherapy Drugs Market, By Value (2013-2023)
6.6 Global Oral Chemotherapy Drugs Market, By Value (2013-2023)
6.7 Other Chemotherapy Drugs Market, By Value (2013-2023)
7. Global Chemotherapy Drugs Market: Regional Analysis
7.1 Global Chemotherapy Drugs Market Size, By Region : Breakdown (%)
7.1.1 Global Chemotherapy Drugs Market Size, By Region, 2017 (%)
7.1.2 Global Chemotherapy Drugs Market Size, By Region, 2023 (%)
7.2 North America Chemotherapy Drugs Market: Growth and Forecast
7.2.1 By Value (2013-2017)
7.2.2 By Value (2018-2023)
7.2.3 By Type of Drug, By Value (2013-2017)
7.2.4 By Type of Drug, By Value (2018-2023)
7.2.5 By Route of Administration, By Value (2013-2017)
7.2.6 By Route of Administration, By Value (2018-2023)
7.3 North America Chemotherapy Drugs Market: Country Analysis (U.S and Canada)
7.3.1 U.S Chemotherapy Drugs Market, By Value (2013-2023)
7.3.2 Canada Chemotherapy Drugs Market, By Value (2013-2023)
7.4 Europe Chemotherapy Drugs Market: Growth and Forecast
7.4.1 By Value (2013-2017)
7.4.2 By Value (2018-2023)
7.4.3 By Type of Drug, By Value (2013-2017)
7.4.4 By Type of Drug, By Value (2018-2023)
7.4.5 By Route of Administration, By Value (2013-2017)
7.4.6 By Route of Administration, By Value (2018-2023)
7.5 Europe Chemotherapy Drugs Market: Country Analysis (Germany and U.K)
7.5.1 Germany Chemotherapy Drugs Market, By Value (2013-2023)
7.5.2 U.K Chemotherapy Drugs Market, By Value (2013-2023)
7.6 APAC Chemotherapy Drugs Market: Growth and Forecast
7.6.1 By Value (2013-2017)
7.6.2 By Value (2018-2023)
7.6.3 By Type of Drug, By Value (2013-2017)
7.6.4 By Type of Drug, By Value (2018-2023)
7.6.5 By Route of Administration, By Value (2013-2017)
7.6.6 By Route of Administration, By Value (2018-2023)
7.7 APAC Chemotherapy Drugs Market: Country Analysis (India and China)
7.7.1 India Chemotherapy Drugs Market, By Value (2013-2023)
7.7.2 China Chemotherapy Drugs Market, By Value (2013-2023)
7.8 ROW Chemotherapy Drugs Market: Growth and Forecast
7.8.1 By Value (2013-2017)
7.8.2 By Value (2018-2023)
7.8.3 By Type of Drug, By Value (2013-2017)
7.8.4 By Type of Drug, By Value (2018-2023)
7.8.5 By Route of Administration, By Value (2013-2017)
7.8.6 By Route of Administration, By Value (2018-2023)
8. Global Chemotherapy Drugs Market Dynamics
8.1 Global Chemotherapy Drugs Market Drivers
8.2 Global Chemotherapy Drugs Market Restraints
9. Global Chemotherapy Drugs Market Trends
10. Porter Five Force Analysis
11. SWOT Analysis
12. Policy and Regulatory Landscape
14. Company Profiles
14.1 Pfizer
14.2 Eli Lilly & Company
14.3 CELGENE Corporation
14.4 Bristol-Myers Squibb
14.5 Merck & Co., Inc.
14.6 GlaxoSmithKline plc
14.7 Novartis
14.8 Sanofi
14.9 Teva Pharmaceuticals Industries Limited
Executive Summary
Azoth Analytics has released a research report titled "Global IgG Mediated Autoimmune Diseases Biologic Drugs Market (2024 Edition)" which provides a complete analysis of the Global IgG Mediated Autoimmune Diseases Biologic Drugs industry in terms of market segmentatio...
Executive Summary
Azoth Analytics has released a research report titled "Global Antibiotic Drugs Market (2024 Edition)" which provides a complete analysis of the global Antibiotic Drugs industry in terms of market segmentation By Drug Class (Cephalosporin, Penicillin, Macrolides, Fluoro...
Overview of the Global Sex Hormone Drugs Market:
The report discusses everything a marketer requires before investing in the global Sex Hormone Drugs Market during the forecast period 2023-2030. It provides detailed...
Executive Summary
Azoth Analytics has released a research report titled "Incretin Based Drugs Market (2023 Edition)" which provides a complete analysis of the global Incretin Based Drugs industry in terms of market segmentation By Drug Type (Glucagon-like Peptide-1 Receptor Agonists, Di...
Overview of the Global Microecological Drugs Market :
The report discusses everything a marketer requires before investing in the global Microecological Drugs Market during the forecast period 2023-2030. It provide...
Overview of the Global Biosynthesis Peptide Drugs Market:
The report discusses everything a marketer requires before investing in the global Biosynthesis Peptide Drugs Market during the forecast period 2023-2030. It...
Overview of the Global Chemical Synthesis Peptide Drugs Market:
The report discusses everything a marketer requires before investing in the global Chemical Synthesis Peptide Drugs Market during the forecast period 2...
Description
The global veterinary dermatology drugs market exhibits positive growth prospects, forecast to expand at a CAGR of 5.4% between 2023 and 2029 to reach USD 8.08 billion in value. Veterinary dermatology focuses on treating skin diseases and disorders in animal patients, covering both...
Overview of the Global Drug Rehabilitation Drugs Market :
The report discusses everything a marketer requires before investing in the global Drug Rehabilitation Drugs Market during the forecast period 2023-2030. It...
Overview of the Global Rosuvastatin Drugs Market:
The report discusses everything a marketer requires before investing in the global Rosuvastatin Drugs Market during the forecast period 2023-2030. It provides detail...